CBJ reports 12 new COVID-19 cases in Juneau
The City and Borough of Juneau Emergency Operations Center is reporting 12 new individuals identified with COVID-19 in Juneau – 11 are residents and one is a nonresident. Of the resident cases, Public Health is attributing nine to secondary transmission, one to out-of-state travel, and one is under investigation. The nonresident case is in the mining sector.
Seven of the new cases are staff and residents at long-term care facility Wildflower Court. The facility has been quarantining since early this week after a second staff member tested positive over the weekend; the first staff member received a positive test result last Friday. Public Health says the potential risk of exposure to the public is low. The current size of the cluster is nine – five residents and four staff. All are asymptomatic so far. Within the facility, seventy percent of staff and residents have received both doses of vaccine. The nine positive cases are a mix of individuals who’ve received no doses, received one dose, or received both.
Cumulatively, Juneau has had 1,065 residents test positive for COVID-19 since March and 136 nonresidents. Five previously unreported cases were added to the resident total due to data verification procedures. There are 37 active cases in Juneau and 1,159 individuals have recovered. All individuals with active cases of COVID-19 are in isolation.
Statewide, the Alaska Department of Health and Social Services (DHSS) today reports 184 new people identified with COVID-19 – 178 are residents and six are nonresidents. The state also reports a recent death – a female North Pole resident in her 40s – bringing the total number of resident deaths to 260. Alaska has had 52,150 cumulative resident cases of COVID-19 and a total of 1,727 nonresidents.
Vaccine information
According to DHSS, 4,906 people in the Juneau region have received their first dose of COVID-19 vaccine – either Pfizer or Moderna – and 1,349 have completed both doses. Statewide, 87,707 people have received their first dose and 22,692 have completed both doses.